Amylyx Pharmaceuticals, Inc. AMLX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s operating lease ROU assets?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported operating lease ROU assets of $4.88M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s operating lease ROU assets increased by 288.6% year-over-year, from $1.26M to $4.88M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s operating lease ROU assets?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a -2.1% compound annual growth rate (CAGR), from $5.52M to $5.18M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.